NEW YORK – Calibre Scientific said on Wednesday that it has acquired San Mateo, California-based sequencing sample prep reagent manufacturer BrightBox Quantitation.
Financial and other terms of the transaction were not disclosed.
BrightBox Quantitation produces and distributes an assay kit for the rapid quantification of next-generation sequencing libraries. According to BrightBox’s website and LinkedIn page, the company produces one type of product and has no more than 10 employees.
Los Angeles-based Calibre said BrightBox will join its EdgeBio division, and the acquisition will enhance the company’s presence in the DNA sequencing sector.
“We're excited to add BrightBox Quantitation kits to our portfolio: They will make NGS workflows faster, easier, and more cost-effective for our customers, allowing them to increase throughput capacity and deliver consistent, high-quality results,” EdgeBio’s general manager Avesta Ebrahimi said in a statement.
Early this month, Calibre acquired AmpliTech, a French life science reagent and instrument distributor. Also, in late 2020, Calibre acquired Ontario-based life science product distributor Canadian Life Science.
Calibre did not respond to a request for additional information before deadline.